Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Copper homeostasis protein cutC homolog (CUTC) is a human intracellular protein of the Cut family, with a TIM-barrel fold and tetrameric structure that binds cuprous ion (Cu(I)) at a specific site involving conserved cysteine residues. Recent biochemical and structural analyses demonstrate that human CUTC does not function primarily as a membrane copper transporter; instead, it acts as a copper-binding enzyme, with Cu(I) serving as a cofactor. CUTC plays a role in copper homeostasis and intracellular trafficking/metabolism and may safeguard cells from copper-induced cytotoxicity, as silencing CUTC increases apoptotic effects in cells exposed to copper stress. The physiological functions remain incompletely defined, and disease associations have not been robustly characterized. There are currently no known drugs targeting CUTC directly, and its primary significance is in basic copper metabolism and cellular health, rather than as an established clinical therapeutic target.
Not established; no known drugs targeting CUTC
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Copper homeostasis protein cutC homolog (CUTC).